Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
This phase II trial is studying how well saracatinib works in treating patients with stage
III or stage IV melanoma that cannot be removed by surgery. Saracatinib may stop the growth
of tumor cells by blocking some of the enzymes needed for cell growth